Alvocidib in Combination With Decitabine and Venetoclax in Patients With Relapsed or Refractory AML or as Frontline Therapy in Unfit Patients With AML
Clinical trial NCT04493099 · WITHDRAWN
Trial details
- NCT number
- NCT04493099
- Sponsor
- M.D. Anderson Cancer Center
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-01
- Primary completion
- 2020-10-12
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.